Evidence map›Paper›PMID 40924108›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Editorial Expression of Concern: HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia-reperfusion injury in rats.

Hai-Quan Tao, Qingfeng Meng, Ming-Hui Li, Hui Yu, Mei-Fang Liu, Dan Du, Shou-Li Sun, Hai-Cheng Yang, Yan-Ming Wang, Wei Ye and 4 more

Abstract readExpression of Concern
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Hai-Quan TaoDepartment of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Qingfeng MengDepartment of Ophthalmology, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Ming-Hui LiDepartment of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China.
Hui YuDepartment of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China.
Mei-Fang LiuDepartment of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China.
Dan DuDepartment of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China.
Shou-Li SunDepartment of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China.
Hai-Cheng YangDepartment of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yan-Ming WangDepartment of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China.
Wei YeDepartment of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Li-Zhuang YangDepartment of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Da-Ling ZhuDepartment of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China.
Chuan-Lu JiangDepartment of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China. jcl6688@163.com.
Hai-Sheng PengDepartment of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China. fisher1688@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40924108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.